Skip to content
NYSE · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS · SMALL CAP

Flyte Aviation, Inc. VJET

9 fiscal years on record · USD · FY2025 reported · SEC filings only
$819,000
▲ 95.0% YoY
$-17.2M
$-8.3M

Slide the table for earlier years · "·" marks a figure not available in our data for that year.

Growth

USD 819,000.00
Revenue, FY2025 · full 9-year series below
Revenue $M Net income $M
FY2025 · Revenue 0.8 · Net income -17.2
-25.0M-50.0M
2017202020232025
Compound annual growth
+288.2%
+25.9%
3 yrs
5 yrs
10 yrs
15 yrs

Revenue compounded at +25.9% a year over the five years to FY2025.

Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.

Profitability

·
Operating margin Net margin
FY2025 · Operating -2581.6% · Net ·
-50000%-100000%-150000%
201720212025
ROE
FY2025 · ROE -182.7%
-200%-400%
201720212025
Three returns, three denominators.

Each USD of equity lost 183 cents this year.

Cash & shareholders

·
returned in FY2025 · dividends + net buybacks
Free cash flow $M
FY2025 · FCF -8.3
-15M-30M
201720212025

Total assetsUSD 15.9M
EquityUSD 7.1M
CashUSD 88,000.00
Gross debtUSD 3.1M
Net debtUSD 3.0M
Current ratio0.10×

Net debt stands at 42% of equity.

The 9-year record

9 fiscal years
Every figure from documents filed with the SEC · USD

EPS, diluted, dividend per share and shares outstanding are shown without shading, and a vertical line marks the year the share count changed — the series crosses a large, unexplained change in share count, so the years on either side are not on a comparable scale.

row low → row highnegative—not applicable◌not available in our data
VJET, 9-year financial record
Metric 202520242023202220212020201920182017
Revenue $B0.00.00.00.00.00.00.00.00.0
Operating income $B−0.0−0.0−0.1−0.0−0.0−0.0−0.1−0.0−0.0
EBITDA $B−0.0−0.0−0.1−0.0−0.0−0.0−0.1−0.0−0.0
Income tax $B−0.00.00.00.00.00.00.00.00.0
Net income $B−0.0−0.0−0.1−0.0−0.0−0.0−0.1−0.0−0.0
Free cash flow $B−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0
EPS, diluted $◌◌◌−25.98−248.22−21.22−108.28−3.34−2.35
Dividend / sh $◌◌◌◌◌◌◌◌◌
Payout % — not applicable: no dividend—————————
ROE %−182.7−101.0−463.5−234.3−144.0−132.8−114.1——
Shares out B0.000.010.010.000.000.000.010.010.01

Slide the table for earlier years. "—" not applicable · "◌" not available in our data.

More in this sector

Other companies filing in the same sector

Provenance

Company facts, as filed

How we verify · 0 failures in 45 reconciliationsAUDITED

Reconciled in 9 of the 9 fiscal years we could check. 20 checks were skipped: the balance sheet is not tagged before 2017. 10 checks were skipped: EPS is not tagged before 2017. 10 checks were skipped: revenue is not tagged before 2017.

EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidityCurrency consistency0 failures
ActivitySurgical & Medical Instruments & Apparatus
Listed onNYSE
Incorporated inDelaware
Fiscal year endsDecember 31
SEC categorysmaller reporting company
Data on record since2017

Share this section

Download image